Clinical Watch: December 2018

January 7, 2019

In this issue of Clinical Watch, we describe expanded uses of Hemlibra® and suggest criteria for the use of Dupixent® to treat severe asthma. We also review a study evaluating factors associated with non-adherence to essential chronic medications. Lastly, we review the prevalence of opioid polypharmacy in two Medicaid pharmacy programs.

For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
Healthcare Providers, Patient Safety and the Role of Digital Technology
Healthcare Providers, Patient Safety and the Role of Digital Technology

Next Flipbook
Clinical Watch: November 2018
Clinical Watch: November 2018

In October 2018, the FDA approved an expanded indication of the HPV vaccine Gardasil 9® to include females ...